FLASH radiotherapy: Considerations for multibeam and hypofractionation dose delivery
Authors
Mackay, Ranald IBurnet, Neil G
Lowe, Matthew
Rothwell, Bethany C
Kirkby, Norman
Kirkby, Karen J
Hendry, Jolyon H
Affiliation
Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UKIssue Date
2021
Metadata
Show full item recordCitation
MacKay R, Burnet N, Lowe M, Rothwell B, Kirkby N, Kirkby K, et al. FLASH radiotherapy: Considerations for multibeam and hypofractionation dose delivery. Vol. 164, Radiotherapy and Oncology. Elsevier BV; 2021. p. 122�7.Journal
Radiotherapy and OncologyDOI
10.1016/j.radonc.2021.09.011PubMed ID
34563608Additional Links
https://dx.doi.org/10.1016/j.radonc.2021.09.011Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.radonc.2021.09.011
Scopus Count
Collections
Related articles
- In regard to MacKay et al: FLASH radiotherapy: Considerations for multibeam and hypofractionation dose delivery.
- Authors: van Marlen P, Dahele M, Slotman BJ, Verbakel WFAR
- Issue date: 2022 Feb
- Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial.
- Authors: Fransson P, Nilsson P, Gunnlaugsson A, Beckman L, Tavelin B, Norman D, Thellenberg-Karlsson C, Hoyer M, Lagerlund M, Kindblom J, Ginman C, Johansson B, Björnlinger K, Seke M, Agrup M, Zackrisson B, Kjellén E, Franzén L, Widmark A
- Issue date: 2021 Feb
- Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO survey.
- Authors: Rodin D, Tawk B, Mohamad O, Grover S, Moraes FY, Yap ML, Zubizarreta E, Lievens Y
- Issue date: 2021 Apr
- How will the CHHiP trial affect the future of prostate radiotherapy?
- Authors: Dearnaley D, Hall E
- Issue date: 2018 Jul
- Late toxicity in the randomized multicenter HYPRO trial for prostate cancer analyzed with automated treatment planning.
- Authors: Sharfo AWM, Dirkx MLP, Bijman RG, Schillemans W, Breedveld S, Aluwini S, Pos F, Incrocci L, Heijmen BJM
- Issue date: 2018 Aug